CMI_LatestReportOrientedBlogs

Macrophage Marker Market Macrophages play a crucial role in regulating both innate and adaptive immune responses in the human body. Macrophage markers help in identifying and studying macrophages and their phenotype using techniques such as flow cytometry and immunophenotyping. The rise in prevalence of chronic diseases such as cancer and autoimmune diseases is fueling the demand for immunophenotyping to study disease pathology at the cellular level. This is driving the need for specific cell surface markers to identify macrophage subpopulations involved in various disease conditions. The global Macrophage Marker Market is estimated to be valued at US$ 256.2 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The increasing adoption of immunophenotyping techniques for disease diagnosis and monitoring presents a major market opportunity for macrophage marke

Lyme Disease Treatment Market  Lyme disease is a bacterial infection caused by Borrelia burgdorferi that is transmitted to humans through the bite of infected blacklegged ticks. Early symptoms may include fever, headache, fatigue, and skin rash known as erythema migrans. If left untreated, later symptoms can involve joints, heart, and nervous system. Lyme disease has been recognized as an emerging public health concern worldwide and suitable precautions are required to avoid contracting this zoonotic infection. Lyme disease treatment involves use of oral or intravenous antibiotics such as doxycycline, amoxicillin or cefuroxime. Various diagnostic tests such as ELISA, Western Blot are used to confirm Lyme disease. The global Lyme Disease Treatment Market is estimated to be valued at US$ 1.56 Bn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: With rising inci

Sevoflurane Market Sevoflurane, an inhaled general anesthetic, is increasingly being used in clinical practices due to its low blood-gas partition coefficient and non-pungent odor. It allows rapid induction and emergence from general anesthesia. Sevoflurane provides an ideal induction characteristic, cardiovascular stability, non-irritation of the airways and organs, and a rapid awakening with minimal side effects. The Global Sevoflurane Market is estimated to be valued at US$ 386.49 Mn in 2023 and is expected to exhibit a CAGR of 9.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Demand for improved safety in anesthesia- Sevoflurane demonstrates improved cardiovascular safety compared to other inhalational anesthetics making it suitable even for high-risk patients. It ensures stable hemodynamics with lesser tendencies of respiratory depression and airway irritation. The unique properties make it the

West Nile Virus Market West Nile virus (WNV) is transmitted by Culex species mosquitoes and is the leading cause of mosquito-borne disease in the continental United States. WNV diagnostics and therapeutics products play a vital role in screening blood donations, organ donations and tissue donations for the presence of West Nile virus. Some of the commonly used WNV diagnostic products include PCR Assays, ELISA/Immunosorbent Assay Kits and rapid diagnostic tests. Therapeutic products include antiviral medications and vaccine. The global West Nile Virus Diagnostics and Therapeutics Market is estimated to be valued at US$ 634.8 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity The market opportunity lies in disease prevention and control. Rising initiatives by governmental and non-governmental organizations towards reducing the burden of WNV disease through

Oral Thin Films Market The Oral Thin Films Market is estimated to be valued at US$ 2895.55 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. arket Overview: Oral thin films (OTF) are thin flexible films manufactured using hydrophilic polymers that are placed on the tongue or buccal cavity for drug delivery. Oral thin films dissolve or disintegrate rapidly in the oral cavity within seconds without water. They provide advantages of accurate dosing, quick absorption, and rapid onset of action which makes them more patient compliant compared to other conventional dosage forms. Market key trends: Preference for patient centric products among consumers is driving the growth of the oral thin films market. Oral thin films provides solution for dysphagia patients who have difficulty in swallowing conventional tablets and capsules. They are also considered as an alternative for pedia

Nausea Medicine Market The nausea medicine market is estimated to be valued at US$ 7.52 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Nausea medicines are used to relief nausea and vomiting caused by conditions like motion sickness, nausea due to cancer treatments like chemotherapy and radiotherapy, pregnancy-induced nausea etc. These medicines work by blocking the body's response to nausea-triggering signals in the brain and stomach. They are available over-the-counter as well prescription and come in forms of tablets, capsules, syrups and injections depending on the condition. The easy availability and effectiveness of these medicines in relieving patients of nausea have increased their demand globally. Market key trends: One of the key trends driving the nausea medicine market growth is improving accessibility of these drugs. Various initiatives

Nootropics Brain Supplements Market The Nootropics Brain Supplements Market is estimated to be valued at US$ 4.1 Bn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Nootropics brain supplements are products that aim to improve brain function including memory, concentration, focus, cognition and overall mental performance. These supplements contain ingredients such as DMAE, acetyl-l-carnitine, vinpocetine, Huperzine A and phytonutrients which provide nutrients essential for brain health. Increasing consumer awareness about brain health and cognition support drives the demand for nootropics brain supplements globally. Market key trends: One of the major trends in the nootropics brain supplements market is increasing adoption of brain health supplements. Consumers are focusing more on brain health and cognitive functions due to ageing populations and growing con

Integrase Inhibitors Market The integrase inhibitors market is estimated to be valued at US$ 29.34 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Integrase inhibitors are used to treat HIV infection by blocking the integrase enzyme and preventing viral DNA from integrating into the genetic material of human cells. Some key integrase inhibitors products include Isentress, Biktarvy, Genvoya and others. These drugs have shown high efficacy in suppressing HIV and are widely adopted as first-line treatment options. Market Dynamics: The integrase inhibitors market is driven by the rising prevalence of HIV/AIDS worldwide and growing adoption of generic integrase inhibitors. According to UNAIDS, around 38 million people were living with HIV globally in 2020. Furthermore, integrase inhibitors have demonstrated superior antiviral potency and higher barrier to resis

Escherichia Coli Strain Market The Escherichia Coli Strain Market is estimated to be valued at US$ 1.97 Bn or Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Escherichia coli (E. coli) is a gram-negative, facultative anaerobic, rod-shaped bacterium commonly found in the lower intestine of warm-blooded organisms. E. coli strains are widely used in biotechnology as they are easy to grow and manipulate. Various E. coli strains are used for the production of therapeutic proteins including insulin, growth factors, and monoclonal antibodies. They are also used in molecular biology techniques such as cloning and protein expression. Market Dynamics: One of the key drivers for the E. coli strain market is increasing demand for biopharmaceuticals. Recombinant therapeutic proteins developed using E. coli strains are gaining acceptance over conventional drugs due

Transdermal Skin Patches Market   The Transdermal Skin Patches Market is estimated to be valued at US$ 7,695.0 Mn in 2022  and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Transdermal skin patches are adhesive patches that deliver medication through the skin and into the bloodstream. These patches are widely used for the treatment of various chronic diseases such as hypertension, diabetes, pain management, and nicotine addiction. They offer several advantages over traditional drug delivery methods, such as controlled and continuous drug release, reduced side effects, improved patient compliance, and convenience. The demand for transdermal skin patches is increasing due to the rising prevalence of chronic diseases and the growing preference for non-invasive drug delivery systems. Market Dynamics: The market for transdermal skin patches is primarily driven by the inc

Medical Nutrition Market The India Medical Nutrition Market is estimated to be valued at US$ 466.5 million in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Medical nutrition refers to nutritional products that are used to meet the needs of patients having malnutrition or certain diseases as well as the needs of individuals wishing to supplement their intake of certain vitamins and minerals. These products include both nutritional supplements taken orally and specific nutritional products used enterally, via a tube feeding. They help meet the additional nutritional needs of patients suffering from conditions including cancer, gastrointestinal disorders, neurological disorders, diabetes, etc. Medical nutrition has an advantage over conventional foods as it provides balanced nutritional support to patients who are unable to meet their dietary requirements through no

India Immuno-Oncology Drugs Market The India Immuno-Oncology Drugs Market is estimated to be valued at US$ 338.98 Mn or Mn in 2023 and is expected to exhibit a CAGR of 13.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Immuno-oncology drugs involve activation of the immune system and immune responses against cancerous cells. They are classified into various types such as monoclonal antibodies, checkpoint inhibitors, targeted cancer immunotherapies, and non-specific immunotherapies. Key products available in the market are Nivolumab, Pembrolizumab, Atezolizumab, and Durvalumab. These help enhance the immune system's ability to fight against cancer by blocking tumor growth and spreading to other parts of the body. Market Dynamics: The India immuno-oncology drugs market is primarily driven by the rising prevalence of various cancers in India. According to World Health Organization (WHO), cancer burde